Half-Life Cancer Research Results

Half-Life, Half-Life: Click to Expand ⟱
Source:
Type:
For many drugs, the half-life is the time it takes for half of the drug’s active substance to be eliminated from the bloodstream.
In medicine, knowing a drug’s half-life helps in designing treatment regimens that reduce adverse effects.


Nor, Normal Healthy: Click to Expand ⟱
Normal Healthy

Scientific Papers found: Click to Expand⟱
2569- ART/DHA,    A semiphysiological pharmacokinetic model for artemisinin in healthy subjects incorporating autoinduction of metabolism and saturable first-pass hepatic extraction
- Human, Nor, NA
*Half-Life↝, BioAv↝, *Half-Life↓, BioAv↑, *Dose↝,
2570- ART/DHA,    Discovery, mechanisms of action and combination therapy of artemisinin
- Review, Nor, NA
*BioAv↓, *Half-Life↓, *toxicity↓, *ROS↑, GSH↓, selectivity↑,
5400- ASA,    Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention
- Review, Nor, NA
Risk↓, *Inflam↓, *COX1↓, *AntiAg↑, *Half-Life↓, *BioAv↑,
5393- Ash,    Studies on oral bioavailability and first-pass metabolism of withaferin A in rats using LC-MS/MS and Q-TRAP
- in-vivo, Nor, NA
*BioAv↝, *other↝, *Half-Life↓,
5858- CAP,    Capsaicin as a Microbiome Modulator: Metabolic Interactions and Implications for Host Health
- Review, Nor, NA - Review, AD, NA
*BBB↓, *GutMicro↑, Obesity↓, *Inflam↓, *AntiCan↑, *TRPV1↑, *Ca+2↑, *antiOx↑, *cardioP↑, *BioAv↓, *Half-Life↓, *BioAv↝, *BioAv↑, *neuroP↑, Apoptosis↑, p38↑, ROS↑, MMP↓, MPT↑, Cyt‑c↑, Casp↑, TRIB3↑, NADH↓, SIRT1↓, TumCG↓, TumCMig↓, TOP1↓, TOP2↓, β-catenin/ZEB1↓, *ROS↓, *Aβ↓,
5928- Catechins,    Bioavailability of Tea Catechins and Its Improvement
- Review, Nor, NA
*BioAv↝, *BioAv↓, *ROS⇅, *NRF2↑, *BioAv↑, *Half-Life↓, *BioAv↑, *BioAv↑, BioAv↑,
3099- RES,    Resveratrol and cognitive decline: a clinician perspective
- Review, Nor, NA - NA, AD, NA
*antiOx↑, *ROS↓, *cognitive↑, *neuroP↑, *SIRT1↑, *AMPK↑, *GPx↑, *HO-1↑, *GSK‐3β↑, *COX2↓, *PGE2↓, *NF-kB↓, *NO↓, *Casp3↓, *MMP3↓, *MMP9↓, *MMP↑, *GSH↑, *other↑, *BioAv↑, *memory↑, *GlutMet↑, *BioAv↓, *Half-Life↓, *toxicity∅,

Showing Research Papers: 1 to 7 of 7

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 7

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress

GSH↓, 1,   NADH↓, 1,   ROS↑, 1,  

Mitochondria & Bioenergetics

MMP↓, 1,   MPT↑, 1,  

Core Metabolism/Glycolysis

SIRT1↓, 1,  

Cell Death

Apoptosis↑, 1,   Casp↑, 1,   Cyt‑c↑, 1,   p38↑, 1,  

Proliferation, Differentiation & Cell State

TOP1↓, 1,   TOP2↓, 1,   TumCG↓, 1,  

Migration

TRIB3↑, 1,   TumCMig↓, 1,   β-catenin/ZEB1↓, 1,  

Drug Metabolism & Resistance

BioAv↑, 2,   BioAv↝, 1,   selectivity↑, 1,  

Clinical Biomarkers

TRIB3↑, 1,  

Functional Outcomes

Obesity↓, 1,   Risk↓, 1,  
Total Targets: 22

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress

antiOx↑, 2,   GPx↑, 1,   GSH↑, 1,   HO-1↑, 1,   NRF2↑, 1,   ROS↓, 2,   ROS↑, 1,   ROS⇅, 1,  

Mitochondria & Bioenergetics

MMP↑, 1,  

Core Metabolism/Glycolysis

AMPK↑, 1,   GlutMet↑, 1,   SIRT1↑, 1,  

Cell Death

Casp3↓, 1,   TRPV1↑, 1,  

Transcription & Epigenetics

other↑, 1,   other↝, 1,  

Proliferation, Differentiation & Cell State

GSK‐3β↑, 1,  

Migration

AntiAg↑, 1,   Ca+2↑, 1,   MMP3↓, 1,   MMP9↓, 1,  

Angiogenesis & Vasculature

NO↓, 1,  

Barriers & Transport

BBB↓, 1,  

Immune & Inflammatory Signaling

COX1↓, 1,   COX2↓, 1,   Inflam↓, 2,   NF-kB↓, 1,   PGE2↓, 1,  

Protein Aggregation

Aβ↓, 1,  

Drug Metabolism & Resistance

BioAv↓, 4,   BioAv↑, 6,   BioAv↝, 3,   Dose↝, 1,   Half-Life↓, 7,   Half-Life↝, 1,  

Clinical Biomarkers

GutMicro↑, 1,  

Functional Outcomes

AntiCan↑, 1,   cardioP↑, 1,   cognitive↑, 1,   memory↑, 1,   neuroP↑, 2,   toxicity↓, 1,   toxicity∅, 1,  
Total Targets: 43

Scientific Paper Hit Count for: Half-Life, Half-Life
2 Artemisinin
1 Aspirin -acetylsalicylic acid
1 Ashwagandha(Withaferin A)
1 Capsaicin
1 Catechins
1 Resveratrol
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:49  Cells:%  prod#:%  Target#:1109  State#:%  Dir#:1
wNotes=0 sortOrder:rid,rpid

 

Home Page